Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium
- PMID: 17328580
- DOI: 10.2165/00003088-200746030-00002
Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium
Abstract
The treatment of epilepsy in pregnancy is particularly challenging in that the fetal and maternal risks associated with maternal seizures need to be balanced against the potential teratogenic effects of antiepileptic drugs (AEDs). Pregnancy is known to affect the pharmacokinetics of older-generation AEDs. Understanding such alterations is important in the effort to optimise drug therapy since they may affect seizure control as well as fetal drug exposure. Therapeutic drug monitoring has therefore been recommended to control for changes in the disposition of the older-generation AEDs during pregnancy. Much less is known about gestation-induced alterations in the pharmacokinetics of the newer AEDs that have been introduced in the last 15 years. Lamotrigine is by far the most extensively studied of the newer AEDs. Pronounced alterations have been reported in the apparent clearance of lamotrigine, with an increase of >300% from baseline in late pregnancy in some patients on monotherapy, most likely due to enhanced metabolism. The available data suggest that the corresponding decline in plasma concentrations can be associated with loss of seizure control. More limited data indicate that a similar decline in plasma concentrations of the active monohydroxy derivative of oxcarbazepine may occur in late pregnancy. Preliminary experience also suggests that a significant fall in plasma concentrations of levetiracetam may occur during pregnancy. No systematic information is available on the pharmacokinetics during pregnancy of other newer AEDs (e.g. gabapentin, pregabalin, tiagabine, topiramate or zonisamide). Given the importance of maintaining optimal treatment of epilepsy during pregnancy, therapeutic drug monitoring appears to be justified for lamotrigine and oxcarbazepine in particular. Systematic studies of the effects of pregnancy on the pharmacokinetics of the other newer-generation AEDs are urgently needed.
Similar articles
-
Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?Clin Pharmacokinet. 2006;45(11):1061-75. doi: 10.2165/00003088-200645110-00002. Clin Pharmacokinet. 2006. PMID: 17048972 Review.
-
Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?CNS Drugs. 2006;20(10):791-800. doi: 10.2165/00023210-200620100-00001. CNS Drugs. 2006. PMID: 16999450 Review.
-
Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications.Epilepsia. 2013 Mar;54(3):405-14. doi: 10.1111/epi.12109. Epub 2013 Jan 29. Epilepsia. 2013. PMID: 23360413 Review.
-
Antiepileptic drug pharmacokinetics during pregnancy and lactation.Neurology. 2003 Sep 1;61(6 Suppl 2):S35-42. doi: 10.1212/wnl.61.6_suppl_2.s35. Neurology. 2003. PMID: 14504308 Review.
-
Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy.Clin Pharmacokinet. 2020 Apr;59(4):427-445. doi: 10.1007/s40262-019-00845-2. Clin Pharmacokinet. 2020. PMID: 31912315 Review.
Cited by
-
Management of epilepsy during pregnancy: evidence-based strategies.Future Neurol. 2015 Mar;10(2):161-176. doi: 10.2217/FNL.15.4. Epub 2015 Mar 4. Future Neurol. 2015. PMID: 30774557 Free PMC article.
-
Does oxcarbazepine warrant therapeutic drug monitoring? A critical review.Clin Pharmacokinet. 2008;47(12):767-78. doi: 10.2165/0003088-200847120-00002. Clin Pharmacokinet. 2008. PMID: 19026033 Review.
-
Management of epilepsy during pregnancy: an update.Ther Adv Neurol Disord. 2016 Mar;9(2):118-29. doi: 10.1177/1756285615623934. Epub 2015 Dec 27. Ther Adv Neurol Disord. 2016. PMID: 27006699 Free PMC article. Review.
-
Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide.Ther Adv Neurol Disord. 2022 Jun 11;15:17562864221101687. doi: 10.1177/17562864221101687. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35706844 Free PMC article. Review.
-
Pregnancy and epilepsy: what should we tell our patients?J Neurol. 2009 Jun;256(6):856-62. doi: 10.1007/s00415-009-5062-1. Epub 2009 Mar 1. J Neurol. 2009. PMID: 19252776 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical